China approves two experimental Covid-19 vaccines for clinical trials

A woman holds a small bottle labbeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020.

The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
In March, China have the green-light for another clinical trial for a coronavirus vaccine candidate developed by military-backed China's Academy of Military Medical Sciences and HK-listed biotech firm CanSino Bio, shortly after US drug developer Moderna said it had begun human tests for their vaccine with the U.S. National Institutes of Health. 
Vaccine needed to stop virus spread
The World Health Organization (WHO) said Monday that a safe and effective vaccine would be needed to fully halt the spread of Covid-19, which has killed more than 114,000 people worldwide.
"Our global connectedness means the risk of re-introduction and resurgence of Covid-19 will continue," WHO Director-General Tedros Adhanom Ghebreyesus told a virtual briefing from Geneva, stressing that "ultimately, the development and delivery of a safe and effective vaccine will be needed to fully interrupt transmission."



Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Taylor Swift: 'White supremacy is repulsive. There is nothing worse'

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN - Onyeji Nnaji

GARDEN OF EDEN FOUND IN WEST AFRICA - Onyeji Nnaji

Tulsi Gabbard says impeachment of Trump would be 'terribly divisive' for country

TYPES OF PREPOSITION - Onyeji Nnaji

Marine Charged for Facebook Comments Gets Hearing Date

EGYPTIANS LAMBAST NIGERIAN FOOTBALLERS OVER ‘FREQUENT’ PROTESTS

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji